Baudax Bio (NASDAQ: BXRX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Baudax Bio (NASDAQ: BXRX) through any online brokerage.
The latest price target for Baudax Bio (NASDAQ: BXRX) was reported by Oppenheimer on Monday, May 11, 2020. The analyst firm set a price target for 14.00 expecting BXRX to rise to within 12 months (a possible 1577.25% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Baudax Bio (NASDAQ: BXRX) is $0.8347 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Baudax Bio.
Baudax Bio’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Baudax Bio.
Baudax Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.